SANTORO, ARMANDO
SANTORO, ARMANDO
Dipartimento di Medicina e Chirurgia
A Comparative Study of Methyl-BEAMing and Droplet Digital PCR for MGMT Gene Promoter Hypermethylation Detection
2024-01-01 Macagno, Marco; Pessei, Valeria; Congiusta, Noemi; Lazzari, Luca; Bellomo, Sara Erika; Idrees, Fariha; Cavaliere, Alessandro; Pietrantonio, Filippo; Raimondi, Alessandra; Gusmaroli, Eleonora; Zampino, Maria Giulia; Gervaso, Lorenzo; Ciardiello, Davide; Mondello, Giuseppe; Santoro, Armando; Personeni, Nicola; Bonoldi, Emanuela; Aquilano, Maria Costanza; Valtorta, Emanuele; Siena, Salvatore; Sartore-Bianchi, Andrea; Amatu, Alessio; Bonazzina, Erica Francesca; Bencardino, Katia Bruna; Serini, Guido; Marsoni, Silvia; Barault, Ludovic; Di Nicolantonio, Federica; Maione, Federica
A Phase II Randomized Dose Escalation Trial of Sorafenib in Patients with Advanced Hepatocellular Carcinoma
2013-01-01 Rimassa, L; Pressiani, T; Boni, C; Carnaghi, C; Rota Caremoli, E; Fagiuoli, S; Foa, P; Salvagni, S; Cortesi, E; Tronconi, Mc; Personeni, N; Bozzarelli, S; Banzi, Mc; Fanello, S; Lutman, Fr; Giordano, L; Santoro, A
A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study
2015-01-01 Santoro, A; Gebbia, V; Pressiani, T; Testa, A; Personeni, N; Bajardi, Ea; Foa, P; Buonadonna, A; Bencardino, K; Barone, C; Ferrari, D; Zaniboni, A; Tronconi, Mc; Carteni, G; Milella, M; Comandone, A; Ferrari, S; Rimassa, L
Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma
2010-01-01 Santoro, A; Pressiani, T; Citterio, G; Rossoni, G; Donadoni, G; Pozzi, F; Rimassa, L; Personeni, N; Bozzarelli, S; Rossoni, G; Colombi, S; De Braud, Fg; Caligaris-Cappio, F; Lambiase, A; Bordignon, C
Activity of Pemetrexed on brain metastases from Non-Small Cell Lung Cancer
2010-01-01 Bearz, Alessandra; Garassino, Isabella; Tiseo, Marcello; Caffo, Orazio; Soto-Parra, Hector; Boccalon, Massimo; Talamini, Renato; Santoro, Armando; Bartolotti, Marco; Murgia, Viviana; Berretta, Massimiliano; Tirelli, Umberto
Advanced colorectal liver metastases and surgery after preoperative chemotherapy : is response-based selection enough?
2011-01-01 Personeni, N.; Torzilli, G.; Santoro, A.
Aggressive and Multidisciplinary Local Approach to Iterative Recurrences of Colorectal Liver Metastases
2018-01-01 Vigano, L; Pedicini, V; Comito, T; Carnaghi, C; Costa, G; Poretti, D; Franzese, C; Personeni, N; Del Fabbro, D; Rimassa, L; Scorsetti, M; Santoro, A; Solbiati, L; Torzilli, G
Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy: heterogeneity-related issues and prognostic implications
2016-01-01 Personeni, N; Baretti, M; Bozzarelli, S; Spaggiari, P; Rubino, L; Tronconi, Mc; Fumagalli, U; Rosati, R; Giordano, L; Roncalli, M; Santoro, A; Rimassa, L
Biomarkers in Hepatocellular Carcinoma-Letter
2012-01-01 Personeni, N; Rimassa, L; Santoro, A
Budget impact of bimonthly use of cetuximab in patients diagnosed with metastatic colorectal cancer
2019-01-01 Mennini, Fs; Marcellusi, A; Fabiano, G; Rimassa, L; Santoro, A; Personeni, N
Cabozantinib for the treatment of hepatocellular carcinoma
2019-01-01 Personeni, N; Rimassa, L; Pressiani, T; Smiroldo, V; Santoro, A
Can stereotactic body radiation therapy be a viable and efficient therapeutic option for unresectable locally advanced pancreatic adenocarcinoma? Results of a phase 2 study
2016-01-01 Comito, T; Cozzi, L; Clerici, E; Franzese, C; Tozzi, A; Iftode, C; Navarria, P; D’Agostino, G; Rimassa, L; Carnaghi, C; Personeni, N; Tronconi, Mc; De Rose, F; Franceschini, D; Ascolese, Am; Fogliata, A; Tomatis, S; Santoro, A; Zerbi, A; Scorsetti, M
Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: A retrospective study
2017-01-01 Comito, T; Cozzi, L; Zerbi, A; Franzese, C; Clerici, E; Tozzi, A; Iftode, C; Navarria, P; D'Agostino, G; Fogliata, A; Mancosu, P; Tomatis, S; Carnaghi, C; Personeni, N; Santoro, A; Scorsetti, M
COVID-19 and liver cancer clinical trials: not everything is lost
2020-01-01 D'Alessio, A; Personeni, N; Pressiani, T; Bozzarelli, S; Smiroldo, V; Simonelli, M; Lleo, A; Santoro, A; Rimassa, L
Determinants of Treatment Benefit and Post-Treatment Survival for Patients with Hepatocellular Carcinoma Enrolled in Second-Line Trials after the Failure of Sorafenib Treatment
2022-01-01 Personeni, Nicola; Pressiani, Tiziana; Zanuso, Valentina; Casadei-Gardini, Andrea; D'Alessio, Antonio; Valgiusti, Martina; Dadduzio, Vincenzo; Bergamo, Francesca; Soldà, Caterina; Rizzato, Mario Domenico; Giordano, Laura; Santoro, Armando; Rimassa, Lorenza
Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study
2018-01-01 Baretti, M; Rimassa, L; Personeni, N; Giordano, L; Tronconi, Mc; Pressiani, T; Bozzarelli, S; Santoro, A
Emergence of KRAS-mutation in liver metastases after an anti-EGFR treatment in patient with colorectal cancer: are we aware of the therapeutic impact of intratumor heterogeneity?
2018-01-01 Baretti, M; Personeni, N; Destro, A; Santoro, A; Rimassa, L
Fatal Infusion Reaction to Cetuximab: The Need for Predictive Risk Factors and Safer Patient Selection
2011-01-01 Tronconi, Mc; Sclafani, F; Rimassa, L; Carnaghi, C; Personeni, N; Santoro, A
FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression: A Phase II Study
2015-01-01 Personeni, N; Rimassa, L; Verusio, C; Barni, S; Rubino, L; Bozzarelli, S; Villa, E; Carnaghi, C; Tronconi, Mc; Gerardi, C; Galli, F; Floriani, I; Destro, A; Raschioni, C; Labianca, R; Santoro, A
Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors
2021-01-01 Personeni, Nicola; Pressiani, Tiziana; D'Alessio, Antonio; Prete, Maria Giuseppina; Bozzarelli, Silvia; Terracciano, Luigi; Dal Buono, Arianna; Capogreco, Antonio; Aghemo, Alessio; Lleo, Ana; Lutman, Romano Fabio; Roncalli, Massimo; Giordano, Laura; Santoro, Armando; Di Tommaso, Luca; Rimassa, Lorenza
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A Comparative Study of Methyl-BEAMing and Droplet Digital PCR for MGMT Gene Promoter Hypermethylation Detection | 1-gen-2024 | Macagno, Marco; Pessei, Valeria; Congiusta, Noemi; Lazzari, Luca; Bellomo, Sara Erika; Idrees, Fariha; Cavaliere, Alessandro; Pietrantonio, Filippo; Raimondi, Alessandra; Gusmaroli, Eleonora; Zampino, Maria Giulia; Gervaso, Lorenzo; Ciardiello, Davide; Mondello, Giuseppe; Santoro, Armando; Personeni, Nicola; Bonoldi, Emanuela; Aquilano, Maria Costanza; Valtorta, Emanuele; Siena, Salvatore; Sartore-Bianchi, Andrea; Amatu, Alessio; Bonazzina, Erica Francesca; Bencardino, Katia Bruna; Serini, Guido; Marsoni, Silvia; Barault, Ludovic; Di Nicolantonio, Federica; Maione, Federica | |
| A Phase II Randomized Dose Escalation Trial of Sorafenib in Patients with Advanced Hepatocellular Carcinoma | 1-gen-2013 | Rimassa, L; Pressiani, T; Boni, C; Carnaghi, C; Rota Caremoli, E; Fagiuoli, S; Foa, P; Salvagni, S; Cortesi, E; Tronconi, Mc; Personeni, N; Bozzarelli, S; Banzi, Mc; Fanello, S; Lutman, Fr; Giordano, L; Santoro, A | |
| A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study | 1-gen-2015 | Santoro, A; Gebbia, V; Pressiani, T; Testa, A; Personeni, N; Bajardi, Ea; Foa, P; Buonadonna, A; Bencardino, K; Barone, C; Ferrari, D; Zaniboni, A; Tronconi, Mc; Carteni, G; Milella, M; Comandone, A; Ferrari, S; Rimassa, L | |
| Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma | 1-gen-2010 | Santoro, A; Pressiani, T; Citterio, G; Rossoni, G; Donadoni, G; Pozzi, F; Rimassa, L; Personeni, N; Bozzarelli, S; Rossoni, G; Colombi, S; De Braud, Fg; Caligaris-Cappio, F; Lambiase, A; Bordignon, C | |
| Activity of Pemetrexed on brain metastases from Non-Small Cell Lung Cancer | 1-gen-2010 | Bearz, Alessandra; Garassino, Isabella; Tiseo, Marcello; Caffo, Orazio; Soto-Parra, Hector; Boccalon, Massimo; Talamini, Renato; Santoro, Armando; Bartolotti, Marco; Murgia, Viviana; Berretta, Massimiliano; Tirelli, Umberto | |
| Advanced colorectal liver metastases and surgery after preoperative chemotherapy : is response-based selection enough? | 1-gen-2011 | Personeni, N.; Torzilli, G.; Santoro, A. | |
| Aggressive and Multidisciplinary Local Approach to Iterative Recurrences of Colorectal Liver Metastases | 1-gen-2018 | Vigano, L; Pedicini, V; Comito, T; Carnaghi, C; Costa, G; Poretti, D; Franzese, C; Personeni, N; Del Fabbro, D; Rimassa, L; Scorsetti, M; Santoro, A; Solbiati, L; Torzilli, G | |
| Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy: heterogeneity-related issues and prognostic implications | 1-gen-2016 | Personeni, N; Baretti, M; Bozzarelli, S; Spaggiari, P; Rubino, L; Tronconi, Mc; Fumagalli, U; Rosati, R; Giordano, L; Roncalli, M; Santoro, A; Rimassa, L | |
| Biomarkers in Hepatocellular Carcinoma-Letter | 1-gen-2012 | Personeni, N; Rimassa, L; Santoro, A | |
| Budget impact of bimonthly use of cetuximab in patients diagnosed with metastatic colorectal cancer | 1-gen-2019 | Mennini, Fs; Marcellusi, A; Fabiano, G; Rimassa, L; Santoro, A; Personeni, N | |
| Cabozantinib for the treatment of hepatocellular carcinoma | 1-gen-2019 | Personeni, N; Rimassa, L; Pressiani, T; Smiroldo, V; Santoro, A | |
| Can stereotactic body radiation therapy be a viable and efficient therapeutic option for unresectable locally advanced pancreatic adenocarcinoma? Results of a phase 2 study | 1-gen-2016 | Comito, T; Cozzi, L; Clerici, E; Franzese, C; Tozzi, A; Iftode, C; Navarria, P; D’Agostino, G; Rimassa, L; Carnaghi, C; Personeni, N; Tronconi, Mc; De Rose, F; Franceschini, D; Ascolese, Am; Fogliata, A; Tomatis, S; Santoro, A; Zerbi, A; Scorsetti, M | |
| Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: A retrospective study | 1-gen-2017 | Comito, T; Cozzi, L; Zerbi, A; Franzese, C; Clerici, E; Tozzi, A; Iftode, C; Navarria, P; D'Agostino, G; Fogliata, A; Mancosu, P; Tomatis, S; Carnaghi, C; Personeni, N; Santoro, A; Scorsetti, M | |
| COVID-19 and liver cancer clinical trials: not everything is lost | 1-gen-2020 | D'Alessio, A; Personeni, N; Pressiani, T; Bozzarelli, S; Smiroldo, V; Simonelli, M; Lleo, A; Santoro, A; Rimassa, L | |
| Determinants of Treatment Benefit and Post-Treatment Survival for Patients with Hepatocellular Carcinoma Enrolled in Second-Line Trials after the Failure of Sorafenib Treatment | 1-gen-2022 | Personeni, Nicola; Pressiani, Tiziana; Zanuso, Valentina; Casadei-Gardini, Andrea; D'Alessio, Antonio; Valgiusti, Martina; Dadduzio, Vincenzo; Bergamo, Francesca; Soldà, Caterina; Rizzato, Mario Domenico; Giordano, Laura; Santoro, Armando; Rimassa, Lorenza | |
| Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study | 1-gen-2018 | Baretti, M; Rimassa, L; Personeni, N; Giordano, L; Tronconi, Mc; Pressiani, T; Bozzarelli, S; Santoro, A | |
| Emergence of KRAS-mutation in liver metastases after an anti-EGFR treatment in patient with colorectal cancer: are we aware of the therapeutic impact of intratumor heterogeneity? | 1-gen-2018 | Baretti, M; Personeni, N; Destro, A; Santoro, A; Rimassa, L | |
| Fatal Infusion Reaction to Cetuximab: The Need for Predictive Risk Factors and Safer Patient Selection | 1-gen-2011 | Tronconi, Mc; Sclafani, F; Rimassa, L; Carnaghi, C; Personeni, N; Santoro, A | |
| FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression: A Phase II Study | 1-gen-2015 | Personeni, N; Rimassa, L; Verusio, C; Barni, S; Rubino, L; Bozzarelli, S; Villa, E; Carnaghi, C; Tronconi, Mc; Gerardi, C; Galli, F; Floriani, I; Destro, A; Raschioni, C; Labianca, R; Santoro, A | |
| Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors | 1-gen-2021 | Personeni, Nicola; Pressiani, Tiziana; D'Alessio, Antonio; Prete, Maria Giuseppina; Bozzarelli, Silvia; Terracciano, Luigi; Dal Buono, Arianna; Capogreco, Antonio; Aghemo, Alessio; Lleo, Ana; Lutman, Romano Fabio; Roncalli, Massimo; Giordano, Laura; Santoro, Armando; Di Tommaso, Luca; Rimassa, Lorenza |